Recruitment is a key part of Lindus Health's end-to-end model for trial delivery. A combination of the right channels can recruit for any study and massively boost recruitment rate, no matter the indication.
Our recruitment channels are social media, patient advocacy groups, and our Primary Care Network. In this blog post we'll explore how we work with primary care providers to turbocharge recruitment, as well as to help deliver decentralised trials.
Primary care organisations are the first point of contact for most people seeking treatment for a health condition. They are embedded in the communities they serve and have strong relationships with their patients. So it's a shame that most primary care providers aren't set up to take part in even routine research!
Lindus Health has partnered with these organisations to help with just this. We bridge the gap between primary care organisations and trial sponsors to recruit trial participants representative of the population they are after. We also have deep relationships with a number of these organisations to provide trial delivery services directly to their communities.
Lindus Health has a well-developed network in the UK and will be expanding this internationally in 2022 to cover Europe, the US and Asia.
In the UK, we have strategic partners in each of the major cities and so can cover most research sites. In total our network covers over 5 million patients!
There is a nationwide commitment to do more research! “Research is a core part of the NHS...The NHS will do all it can to ensure that patients, from every part of England, are made aware of research that is of particular relevance to them” (NHS Constitution, 2021). But, the typically manual process for taking part in research doesn't make it easy.
Today, Clinical Research Networks provide research opportunities to GP groups but there is a lot of effort required to check their patient lists for eligible participants, and then subsequently communicate with select patients about the trial. Patients are missing out on innovative treatment options, made available through trials, because their doctor isn’t even aware of a certain trial.
That said, the number of UK patients taking part in health research and clinical studies is higher than ever. In 2020/21, in England alone there were nearly 1.4 million research participants (NIHR, 2021). People want to take part in research and primary care should be at the forefront of this!
At Lindus Health we want to work with partners who are committed to our mission, to accelerate research for the next generation of health companies.
Product Clinic #3: Embedding software engineering efficiency hacks into our clinical trial platform
Heard of dogfooding? No, not feeding your pet! The practice of using your own software to understand how it performs in the real world and catch any issues. Read about this and other software engineering hacks we are using to build better products.
A Fireside Chat with Paul Wicks: How can we make clinical research for digital therapeutics more patient-friendly?
Digital Therapeutics are still a relatively new treatment area and there is a lot to learn about conducting clinical research on them. Find out how Paul Wick's, Digital Health expert, thinks research companies can put the patients first.
Product Clinic #2: Using feedback loops to build better products
Lindus Health's objective is to build better products that hit non-negotiable clinical standards and challenge outdated conventions. How do we do this? Read more here
Why I joined Lindus Health? Ece Kavalci, Machine Learning Engineer
Working towards a good cause. Innovative approaches to solving problems in clinical trial design. Every contribution is valued.
Why I joined Lindus Health? Van Zyl Engelbrecht
The mission to accelerate clinical trial. The focus on making clinical research more patient-centric. The ability to support innovative health companies bring their product to market at a lower cost.
Product Clinic #1: Turning boring technology into exciting products
Don't be put off by the blunt use of the word "boring" to describe our technology. It's one of our guiding principles allowing us to make rapid progress while maintaining high quality standards. Read more here.
James Lind and the Mafia
The story of how James Lind's trial for scurvy led to the formation of the mafia.
What actually improves diversity in clinical research?
We’ve all seen the evidence of ethnic minority underrepresentation but what is actually going to have an impact in the future? Read Lindus Health’s action plan here
Vaccine Trials and Tribulations
Read co-founder Meri’s experience of a Covid-19 vaccine trial that left him frustrated (but vaccinated), and led to the creation of Lindus Health.
Stagnation, Drugs and Eroom's law
Why does the cost of clinical trials continue to increase? Meri Beckwith, Lindus Health co-founder discusses why stagnation has prevailed and how technology is the answer
Cure Scurvy with this one weird trick…! Doctors hate him
In 1747 James Lind conducted the first clinical trial, proving that oranges and lemons were a cure for scurvy. Given that we’re named after him we felt it was about time we wrote a post about the history of scurvy, Lind, and the first ever clinical trial! We believe that in 100 years current health outcomes will seem just as ridiculous and intolerable as 50% of sailors dying of scurvy seems now, and that’s why we’re named Lindus Health.
Why I joined Lindus Health? Luke Twelves, Medical Lead
To help make trials more accessible to patients and clinicians. To help bring novel and innovative treatments to the frontline of care faster. To stretch myself and work as part of a really exciting team.
A success story: Lindus Health recruiting prediabetes patients for the ASPIRE-DNA clinical trial
Lindus Health used its multi-channel strategy to accelerate DnaNudge's trial recruitment. Read more about the challenges they faced and our results here.
Lindus Health launches with $5m seed round to revolutionise health research
Lindus Health publicly launched today, announcing $5m in seed funding from leading technology and healthcare investors including Firstminute Capital, Presight Capital, Seedcamp, Hambro Perks and Amino Collective.